Rocket Pharmaceuticals
RCKT
RCKT
107 hedge funds and large institutions have $744M invested in Rocket Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 120 → 107 (-13)
37% less capital invested
Capital invested by funds: $1.18B → $744M (-$432M)
46% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 28
Holders
107
Holding in Top 10
3
Calls
$430K
Puts
$327K
Top Buyers
| 1 | +$12.3M | |
| 2 | +$12M | |
| 3 | +$6.87M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.74M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.62M |
Top Sellers
| 1 | -$8.06M | |
| 2 | -$6.8M | |
| 3 | -$4.55M | |
| 4 |
Morgan Stanley
New York
|
-$3.89M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.75M |